Over the last five decades, the Indian Pharma industry has grown from strength to strength and built a strong global presence. The industry, off-late, is going through structural changes with increased interest in Biotechnology, multiple companies launching Biosimilars, and the focus moving from infectious diseases to Non-communicable diseases. Companies have realized that the days of ‘low hanging fruit’ are over, and many are trying to launch novel therapies, in relatively less-crowded disease conditions. Innovative physician and patient outreach programs, especially ones leveraging digital platforms are becoming more common.
What We Do
Medium Healthcare Consulting has worked with Indian and global Pharmaceutical companies to develop winning commercialization strategies such as Go-To-Market Strategy, Growth Strategy and India Entry Strategy. Our strong institution and KOL connect, and cross healthcare expertise (MedTech and Healthcare delivery), gives us unique strengths. Our diverse team of senior consultants, conduct all the research on their own, helping derive rich, actionable insights.
Here are some illustrative examples of work we have done:
- Go-to-Market Strategy for a niche dermal substitute for an Indian Pharma MNC
- Launch sales story for an ultra-long acting insulin, for a global Diabetes Major
- Growth Strategy for a Nephrology drug facing prospects of slow growth
Customers who trust us